CN110227049A - 一种保湿白茶面膜 - Google Patents

一种保湿白茶面膜 Download PDF

Info

Publication number
CN110227049A
CN110227049A CN201910664684.8A CN201910664684A CN110227049A CN 110227049 A CN110227049 A CN 110227049A CN 201910664684 A CN201910664684 A CN 201910664684A CN 110227049 A CN110227049 A CN 110227049A
Authority
CN
China
Prior art keywords
facial mask
white tea
emulsifier
moisturizing
tea facial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910664684.8A
Other languages
English (en)
Inventor
杨建忠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anji Ming Tablet Technology Co Ltd
Original Assignee
Anji Ming Tablet Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anji Ming Tablet Technology Co Ltd filed Critical Anji Ming Tablet Technology Co Ltd
Priority to CN201910664684.8A priority Critical patent/CN110227049A/zh
Publication of CN110227049A publication Critical patent/CN110227049A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

一种保湿白茶面膜,包括白茶面膜精华液,包括以下成分,按重量份计:8~12%白茶提取液、3~8%稳定剂、2~8%乳化剂、5~10%保湿剂、0.5~1.5%增稠剂、0.1~0.5%pH平衡剂、2~6%添加剂,余量为水,稳定剂为荷荷巴油和/或琉璃苣油和/或月见草油,乳化剂包括乳化剂A和乳化剂B,乳化剂A为N‑酰胺基及其盐类化合物和/或甜菜碱类两性离子化合物和/或吐温类乳化剂,乳化剂B为司盘类乳化剂,本方案中采用的白茶面膜,因含有高浓度的生物碱类、黄酮类和酚类活性物质,抗氧化、保湿性强,且稳定性强、吸收效果好。

Description

一种保湿白茶面膜
技术领域
本发明涉及日用化学品技术领域,具体来说,涉及一种保湿白茶面膜。
背景技术
面膜,主要是利用覆盖在皮肤的短暂时间,暂时隔离外界的空气与污染,提高肌肤温度,使皮肤的毛孔扩张,促进汗腺分泌与新陈代谢,使肌肤的含氧量上升,有利于肌肤排除表皮细胞新陈代谢的产物和累积的油脂类物质,面膜中的水分渗入肌肤表皮的角质层,皮肤变得柔软,肌肤自然光亮有弹性。
贴式面膜包含面膜布和精华液,面膜布作为介质,吸附精华液,可以固定在脸部特定位置,形成封闭层,促进精华液的吸收;贴式面膜拥有即刻保湿、提亮肤色和改善皮肤纹理的效果,是面膜类产品中销量最大、增长速度最快的一个品类。
天然植物及其提取物类护肤品,温和有效、刺激性小,此类护肤品颇受消费者喜爱;安吉白茶主要产于安吉,为茶中珍品,是中国六大茶类之一,具有养目、养气、养神、养颜的功效,相比绿茶、红茶,安吉白茶中的氨基酸、茶氨酸、咖啡碱、可溶性糖含量高,特别是氨基酸含量明显高于其他茶类;白茶中的儿茶素具有抗氧化、抗菌、增强免疫力的作用;咖啡碱和黄烷醇类成分可以促进血液循环、消除疲劳;活性酶能够显著提高体内酯酶活性,促进脂肪分解代谢,起到控油的作用;茶多糖有抗辐射、抗癌和增强机体自我保护力作用;黄酮类成分具有抗氧化和改善血液循环作用;白茶本身的特殊香气还能舒缓压力,使人放松。
申请号为CN109010170A的文件公开了一种白茶面膜及其制备方法,按照质量份数包括:1-10份白茶叶提取物、1.11-11份保湿剂、0.8-1份添加剂、1-5份茶氨酸、1-5份茶多酚、0.15-1份增稠剂、0.1-2份烟酰胺、1-10份二裂酵母发酵产物溶胞物,并公开其制备方法,将上述组分简单混合;但是茶多酚类物质稳定性低,易被氧化,简单的将其与其他制剂混合制备的面膜液效果难以发挥。
发明内容
针对上述存在的问题,本发明提供一种保湿白茶面膜,通过添加稳定剂减少白茶提取液中的活性物质氧化失活,所得的面膜产品因含有高浓度的生物碱类、黄酮类和酚类活性物质,抗氧化、保湿性强,且稳定性强、吸收效果好。
本发明的技术方案如下:
一种保湿白茶面膜,包括白茶面膜精华液,所述白茶面膜精华液,包括以下成分:按重量份计:8~12%白茶提取液、3~8%稳定剂、2~8%乳化剂、5~10%保湿剂、0.5~1.5%增稠剂、0.1~0.5%pH平衡剂、2~6%添加剂,余量为水;进一步地,稳定剂为荷荷巴油和/或琉璃苣油和/或月见草油,乳化剂包括乳化剂A和乳化剂B,乳化剂A为N-酰胺基及其盐类化合物和/或甜菜碱类两性离子化合物和/或吐温类乳化剂,乳化剂B为司盘类乳化剂。
在本方案设计中,茶多酚类物质具有优良的清除自由基的功能,能有效防止皮肤细胞膜因氧化而损伤,同时还具有美白、消炎杀菌的效果,咖啡碱类物质对皮肤具有镇定的效果;采用稳定剂用于对白茶提取液中的茶多酚、咖啡碱类易氧化、分解的活性物质对其进行包合保护并配合高效的乳化剂使稳定剂与活性物质的混合体系稳定,可有效地保护茶多酚、咖啡碱类活性物质不失活,且本方案中采用的荷荷巴油、琉璃苣油、月见草油等稳定剂对皮肤无害且易吸收,具有多种美肤功效,优选荷荷巴油作为稳定剂,相比琉璃苣油、月见草油,荷荷巴油清爽滋润、保湿效果好,且亲肤性很高,还可作为媒介将白茶提取液中的活性物质带入皮肤促进吸收。
进一步地,乳化剂A为聚氧乙烯脱水山梨醇脂肪酸酯和/或椰油酰胺丙基羟磺基甜菜碱和/或月桂酰胺丙基羟磺基甜菜碱。
在本方案设计中,乳化剂A选用增稠性、亲水性优良且对皮肤无害的表面活性剂,有利于将包合白茶提取的活性物质的稳定剂与其他助剂、添加剂充分混合、分散,形成的稳定、稠度佳的面膜精华液,提高使用感。
进一步地,乳化剂B为失水山梨醇脂肪酸酯。
在本方案设计中,乳化剂B选用常用的失水山梨醇脂肪酸酯,亲油性强,可将白茶提取液与稳定剂形成稳定的油包水混合体系。
进一步地,白茶提取液含有至少15~20%的茶多酚、5~8%的游离氨基酸、3~6%的醛酸。
进一步地,保湿剂包括透明质酸钠和/或丙二醇和/或丁二醇。
进一步地,增稠剂包括卡波姆和/或黄原胶。
进一步地,pH平衡剂为三乙醇胺,三乙醇胺可与酸性高分子凝胶卡波姆等的羧基中和,形成稳定的高分子结构,达到增稠和保湿的应用效果。
进一步地,添加剂包括透皮肽EFG、β-葡聚糖和/或海藻糖。
在本方案设计中,透皮肽EFG可促进活性物质被皮肤吸收,与β-葡聚糖协同作用,可增加面膜精华液的修护功能,降低面部的敏感性;海藻糖可进一步对面膜精华液中的活性成分起到保护作用。
进一步地,添加剂包括维生素A和/或维生素E。
在本方案设计中,维生素A可作为添加剂有助于皮肤柔软丰满,维生素E可起到抗氧化的作用,进一步保护茶多酚等物质不被氧化,同时又具备辅助清除自由基的效果。
优选地,透皮肽EFG与β-葡聚糖的质量比为1:2~1:3,进一步优选地,透皮肽EFG的数均分子量为6000~8000。
与现有技术相比,本发明具备以下有益效果:
本发明采用的面膜精华液中含有高含量的白茶提取液,白茶提取液中的茶多酚、咖啡碱等活性物质含量高,抗氧化、镇静的效果好,同时也能减少黑色素的生成,达到美白的效果。
本发明相比传统的白茶面膜配方,添加了对白茶提取液中茶多酚、咖啡碱等不稳定、易氧化的活性物质起到保护作用的稳定剂,有优良的保护效果同时又能促进皮肤对活性物质的吸收,且对皮肤无害。
本发明还采用了保湿剂、增稠剂、添加剂等多种成分,使面膜精华液具有优良的补水保湿效果,同时面膜的体系更加稳定,具有很好的使用感、舒适感。
具体实施方式
实施例1
一种保湿白茶面膜,其中面膜精华液配方如下:8%白茶提取液、3%荷荷巴油、0.5%失水山梨醇脂肪酸酯、0.08%维生素A、0.1%维生素E、0.1%透明质酸钠、4.5%丙二醇、2%丁二醇、0.3%卡波姆、0.2%黄原胶、0.1%三乙醇胺、0.5%透皮肽EFG、1%β-葡聚糖、1.5%海藻糖、1%椰油酰胺丙基羟磺基甜菜碱、1.5%聚氧乙烯脱水山梨醇脂肪酸酯、75.62%纯化水。
该面膜精华液的制备方法如下:
步骤一:取白茶进行粉碎,过60目筛,过筛后白茶粉末中加入纯化水,白茶粉末与纯化水的料液比为1g:20ml,升温至60~70℃,加入碳酸氢钠调节溶液pH在7.5~9.0区间,浸提1h后过滤,收集滤液;将收集的滤液过吸附树脂AB-8柱进行吸附,上柱流速为1BV/h,然后用100%乙醇进行解吸,将收集的解吸液浓缩干燥至原体积的1/8左右,得到白茶提取液,AB-8柱的吸附选择性好,不受无机盐的影响,因此所得的提取液中茶多酚、游离氨基酸、醛酸含量高,经测试,可达到茶多酚含量>16%,游离氨基酸含量大于6%,醛酸含量>5%的标准;
步骤二:将白茶提取液、维生素A、维生素E、荷荷巴油与失水山梨醇脂肪酸酯按配方配比混合,以6000r/min的转速搅拌10min,然后降低搅拌速度为250r/min,将纯化水以45-50滴/分的速度逐滴加入至混合物中,纯化水的最终加入量为总乳液质量的60%,得到乳状液Ⅰ;
步骤三:按配比将卡波姆加入纯化水中,50℃搅拌溶解,然后加入透明质酸钠、海藻糖、椰油酰胺丙基羟磺基甜菜碱、聚氧乙烯脱水山梨醇脂肪酸酯,90℃混合,得到混合物Ⅱ;
步骤四:在混合物Ⅱ中加入三乙醇胺、丙二醇、丁二醇,60℃、500r/min混合搅拌10min,得到混合物Ⅲ;
步骤五:在得到的混合物Ⅲ中加入黄原胶、β-葡聚糖,40℃、500r/min混合搅拌15min,得到混合物Ⅳ;
步骤六:在得到的混合物Ⅳ中加入透皮肽EFG,30℃、500r/min搅拌混合10min后,加入得到的乳状液Ⅰ,维持30℃,以800r/min的速度搅拌混合20min,得到所述面膜精华液。
将制备的面膜精华液进行卫生化学指标和感官指标测试,如下:
根据QB/T2872-2007进行外观和香气的检测;根据QB/T2872-2007分别对汞、铅、砷、菌落总数、霉菌和酵母总数、粪大肠杆菌、金黄色葡萄球菌、铜绿假单胞菌进行检测,检测结果如下:
由表1的检测结果可知,本实施例制备的面膜精华液的感官指标和卫生化学指标均合格。
实施例2
一种保湿白茶面膜,其中面膜精华液配方如下:12%白茶提取液、8%荷荷巴油、2.5%失水山梨醇脂肪酸酯、1.0%维生素A、1.5%维生素E、1%透明质酸钠、6%丙二醇、3%丁二醇、1.0%卡波姆、0.5%黄原胶、0.5%三乙醇胺、0.5%透皮肽EFG、1.5%β-葡聚糖、2%海藻糖、4%椰油酰胺丙基羟磺基甜菜碱、2.5%聚氧乙烯脱水山梨醇脂肪酸酯、52.5%纯化水。
该面膜精华液的制备方法如下:
步骤一:取白茶进行粉碎,过60目筛,过筛后白茶粉末中加入纯化水,白茶粉末与纯化水的料液比为1g:20ml,升温至60~70℃,加入碳酸氢钠调节溶液pH在7.5~9.0区间,浸提1.5h后过滤,收集滤液;将收集的滤液过吸附树脂AB-8柱进行吸附,上柱流速为1BV/h,然后用100%乙醇进行解吸,将收集的解吸液浓缩干燥至原体积的1/8左右,得到白茶提取液;
步骤二:将白茶提取液、维生素A、维生素E、荷荷巴油与失水山梨醇脂肪酸酯按配方配比混合,以5000r/min的转速搅拌10min,然后降低搅拌速度为300r/min,将纯化水以45-50滴/分的速度逐滴加入至混合物中,纯化水的最终加入量为总乳液质量的40%,得到乳状液Ⅰ;
步骤三:按配比将卡波姆加入纯化水中,50℃搅拌溶解,然后加入透明质酸钠、海藻糖、椰油酰胺丙基羟磺基甜菜碱、聚氧乙烯脱水山梨醇脂肪酸酯,90℃混合,得到混合物Ⅱ;
步骤四:在混合物Ⅱ中加入三乙醇胺、丙二醇、丁二醇,60℃、500r/min混合搅拌10min,得到混合物Ⅲ;
步骤五:在得到的混合物Ⅲ中加入黄原胶、β-葡聚糖,40℃、500r/min混合搅拌15min,得到混合物Ⅳ;
步骤六:在得到的混合物Ⅳ中加入透皮肽EFG,30℃、500r/min搅拌混合10min后,加入得到的乳状液Ⅰ,维持30℃,以800r/min的速度搅拌混合20min,得到所述面膜精华液。
本实施例制备的面膜精华液的感官指标和卫生化学指标均合格,测试方法同实施例1。
设置对比例1,与实施例1的不同之处在于,不添加荷荷巴油。
设置对比例2,与实施例1的不同之处在于,不添加透皮肽EFG,而β-葡聚糖的添加量为实施例1中透皮肽EFG和β-葡聚糖添加量的总和。
设置对比例3,与实施例1的不同之处在于,不添加β-葡聚糖,而透皮肽EFG的添加量为实施例1中透皮肽EFG和β-葡聚糖添加量的总和。
设置对比例4,与实施例1的不同之处在于,不添加三乙醇胺。
分别取实施例1~2和对比例1~4的面膜液25ml,将6个相同的面膜纸在面膜精华液中浸润5min,得到面膜。
进行人体试用评价试验,选取皮肤健康志愿者12名,年龄分布在25~30岁,男女比例1:1,随机分成A~F组,每组一男一女;试验前2周,不使用产品及同类产品,每周检测一次;试验时每2日贴附面膜,每次15min,每周测试一次,连续测试3周,测试期间不更换或合用其他同类产品;其中,A组使用的面膜为采用实施例1制备的面膜,B组使用的面膜为采用实施例2制备的面膜,C组使用的面膜为采用对比例1制备的面膜,D组使用的面膜为采用对比例2制备的面膜,E组使用的面膜为采用对比例3制备的面膜,F组使用的面膜为采用对比例4制备的面膜;分别用CM825皮肤水份测试仪、MPA580皮肤弹性测试仪和VISIA全脸分析仪分别对志愿者进行测试评价,其中最高分为5分,最低分为0分,评价结果如下:
如上表可知,实施例1~2制备的面膜具有优良的保湿性,可增加皮肤的弹性,降低敏感性,且具有优良的镇静效果;由对比例1可知,未添加稳定剂制备的白茶面膜,因白茶活性物质部分失活,使得产品的镇静性降低明显,同时荷荷巴油具有促进皮肤吸收的效果,因此保湿性和弹性都有降低;由对比例2可知,这与缺少透皮肽EFG的导入皮肤效果而使得保湿度、弹性、消炎镇静性都降低了,而缺少β-葡聚糖和透皮肽EFG配合的降敏效果,皮肤敏感性提高了;由对比例3可知,未添加β-葡聚糖,产生与透皮肽EFG配合的降敏效果,皮肤的敏感性提高了;由对比例4可知,未添加三乙醇胺,使得体系的pH值失衡,整体的保湿度、弹性、消炎镇静性都大大降低,而皮肤敏感性提高了。
本文中所描述的具体实施例仅仅是对本发明精神作举例说明。本发明所属技术领域的技术人员可以对所描述的具体实施例做各种各样的修改或补充或采用类似的方式替代,但并不会偏离本发明的精神或者超越所附权利要求书所定义的范围。

Claims (10)

1.一种保湿白茶面膜,包括白茶面膜精华液,所述白茶面膜精华液,包括以下成分:按重量份计:8~12%白茶提取液、3~8%稳定剂、2~8%乳化剂、5~10%保湿剂、0.5~1.5%增稠剂、0.1~0.5%pH平衡剂、2~6%添加剂,余量为水;所述稳定剂为荷荷巴油和/或琉璃苣油和/或月见草油,所述乳化剂包括乳化剂A和乳化剂B,所述乳化剂A为N-酰胺基及其盐类化合物和/或甜菜碱类两性离子化合物和/或吐温类乳化剂,所述乳化剂B为司盘类乳化剂。
2.根据权利要求1所述的一种保湿白茶面膜,其特征在于,所述乳化剂A为聚氧乙烯脱水山梨醇脂肪酸酯和/或椰油酰胺丙基羟磺基甜菜碱和/或月桂酰胺丙基羟磺基甜菜碱。
3.根据权利要求1所述的一种保湿白茶面膜,其特征在于,所述乳化剂B为失水山梨醇脂肪酸酯。
4.根据权利要求1所述的一种保湿白茶面膜,其特征在于,所述白茶提取液含有至少15~20%的茶多酚、5~8%的游离氨基酸、3~6%的醛酸。
5.根据权利要求1所述的一种保湿白茶面膜,其特征在于,所述保湿剂包括透明质酸钠和/或丙二醇和/或丁二醇。
6.根据权利要求1所述的一种保湿白茶面膜,其特征在于,所述增稠剂包括卡波姆和/或黄原胶。
7.根据权利要求6所述的一种保湿白茶面膜,其特征在于,所述pH平衡剂为三乙醇胺。
8.根据权利要求1~7任一所述的一种保湿白茶面膜,其特征在于,所述添加剂包括透皮肽EFG、β-葡聚糖和/或海藻糖。
9.根据权利要求8所述的一种保湿白茶面膜,其特征在于,所述添加剂包括维生素A和/或维生素E。
10.根据权利要求8所述的一种保湿白茶面膜,其特征在于,所述透皮肽EFG与β-葡聚糖的质量比为1:2~1:3。
CN201910664684.8A 2019-07-23 2019-07-23 一种保湿白茶面膜 Pending CN110227049A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910664684.8A CN110227049A (zh) 2019-07-23 2019-07-23 一种保湿白茶面膜

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910664684.8A CN110227049A (zh) 2019-07-23 2019-07-23 一种保湿白茶面膜

Publications (1)

Publication Number Publication Date
CN110227049A true CN110227049A (zh) 2019-09-13

Family

ID=67855903

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910664684.8A Pending CN110227049A (zh) 2019-07-23 2019-07-23 一种保湿白茶面膜

Country Status (1)

Country Link
CN (1) CN110227049A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336661A (zh) * 2020-11-10 2021-02-09 广州环亚化妆品科技有限公司 一种茶多酚面膜精华液、茶多酚面膜布及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599021A (zh) * 2013-11-15 2014-02-26 上海应用技术学院 一种洛神花提取物及其制备方法和其在美白护肤用化妆品中的应用
CN107375080A (zh) * 2017-08-04 2017-11-24 遵义医学院 一种白茶补水睡眠面膜及其制备方法
CN109010170A (zh) * 2018-08-28 2018-12-18 李宗优 一种白茶面膜及其制备方法
CN109303745A (zh) * 2018-11-29 2019-02-05 广州暨创医美生物科技有限公司 一种面膜液、其制备方法和包含该面膜液的面膜及其面膜的应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599021A (zh) * 2013-11-15 2014-02-26 上海应用技术学院 一种洛神花提取物及其制备方法和其在美白护肤用化妆品中的应用
CN107375080A (zh) * 2017-08-04 2017-11-24 遵义医学院 一种白茶补水睡眠面膜及其制备方法
CN109010170A (zh) * 2018-08-28 2018-12-18 李宗优 一种白茶面膜及其制备方法
CN109303745A (zh) * 2018-11-29 2019-02-05 广州暨创医美生物科技有限公司 一种面膜液、其制备方法和包含该面膜液的面膜及其面膜的应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336661A (zh) * 2020-11-10 2021-02-09 广州环亚化妆品科技有限公司 一种茶多酚面膜精华液、茶多酚面膜布及其制备方法和应用

Similar Documents

Publication Publication Date Title
US8101214B2 (en) Composition for skin external application containing complex of herbal extracts
CN110302110A (zh) 一种美白抗氧化白茶面膜的制备工艺及其面膜产品
US8808761B2 (en) Composition of skin external application containing rose extract and epigallocatechin gallate(EGCG)
CN107998016A (zh) 一种具有祛斑美白功效的化妆品原料组合物
KR20180052823A (ko) 천연 방부제 화장료 조성물 및 물티슈 용액
CN104274357B (zh) 一种含有植物酊剂的头皮护理组合物及其制备方法
CN108619078A (zh) 一种美白亮肤面膜及其制备方法
CN107375080A (zh) 一种白茶补水睡眠面膜及其制备方法
KR20130030032A (ko) 허브 추출물을 포함하는 화장료 조성물
CN105998195A (zh) 一种具有抗敏感保湿作用的汉麻提取物及其应用
KR101606393B1 (ko) 화산석 송이를 함유하는 화장료 조성물
KR101317430B1 (ko) 진달래꽃, 사과꽃 및 함박꽃 추출물을 함유하는 보습 및 진정 화장용 조성물
CN105560155A (zh) 含有山羊奶的化妆品组合物及其应用
CN110420143A (zh) 一种含有九品香水莲花提取物的凝露及其制备方法
CN112057411A (zh) 一种深层修复的山茶纯露面膜及其制备方法
CN105310935A (zh) 一种黑果枸杞组合免洗睡眠面膜
CN109939043B (zh) 疗伤绒毛花地上部分的醇提取物、获得它的方法、以及包含它的化妆品或药物组合物
CN110227049A (zh) 一种保湿白茶面膜
KR100962344B1 (ko) 블랙헤드 제거용 화장료 조성물
KR101453281B1 (ko) 화장료 조성물
KR101191140B1 (ko) 장딸기 열매 추출물 및 마유를 함유하는 피부 보호용 화장료 조성물
CN107334677A (zh) 一种婴儿滋润护肤霜
CN111973487A (zh) 一种神经酰胺保湿精华及其制备方法
CN105232402A (zh) 一种具有护肤功效的组合物
KR101437336B1 (ko) 침엽수잎 발효 추출물을 함유하는 모발 및 두피 개선용 천연 세정제 조성물 및 이의 제조방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190913